DR. ANNA PARK MD
Prescription History 1295730521
Ophthalmology in Silver Spring, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ANNA PARK MD, an active Ophthalmology specialist practicing in Silver Spring, MD. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 359 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 152 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MD PrescribersVs. MD Avg |
|---|---|---|---|
| Latanoprost | 152 | $13.58▼ below MD avg | ≈ Typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 152 Medicare prescriptions for Latanoprost, about the same volume as the typical Maryland prescriber of this medication (136.4). Medicare paid an average of $13.58 per fill, versus $14.32 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 378.7 30-Day Fills standardized to 30-day supplies 11,315 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 56 | $70.54 | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 56 Medicare prescriptions for Timolol Maleate, about 72% of the volume of the typical Maryland prescriber of this medication (78.2). Medicare paid an average of $70.54 per fill, versus $22.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 140.3 30-Day Fills standardized to 30-day supplies 4,192 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 32 | $14.32▼ below MD avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 32 Medicare prescriptions for Dorzolamide-Timolol, about a third of the volume of the typical Maryland prescriber of this medication (97.8). Medicare paid an average of $14.32 per fill, versus $21.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 72.1 30-Day Fills standardized to 30-day supplies 2,162 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 25 | $78.64 | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 25 Medicare prescriptions for Brimonidine Tartrate, about a third of the volume of the typical Maryland prescriber of this medication (64.9). Medicare paid an average of $78.64 per fill, versus $48.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 65.6 30-Day Fills standardized to 30-day supplies 1,958 Days of Medication total across all patients in 2024 | |||
| Dorzolamide Hcl | 24 | $23.19 | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. Topically effective ocular hypotensive carbonic anhydrase inhibitor. In 2024, this provider wrote 24 Medicare prescriptions for Dorzolamide Hcl, about half the volume of the typical Maryland prescriber of this medication (45.9). Medicare paid an average of $23.19 per fill, versus $21.20 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42.9 30-Day Fills standardized to 30-day supplies 1,228 Days of Medication total across all patients in 2024 | |||
| ErythromycinErythromycin Base | 23 | $9.13▼ below MD avg | ▼ Less than typical |
About Erythromycin: This medication is used to treat certain eye infections (such as conjunctivitis). Show more ▾ It is also used to prevent certain eye infections in newborns. It belongs to a class of drugs known as macrolide antibiotics. Erythromycin works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. In 2024, this provider wrote 23 Medicare prescriptions for Erythromycin, about 70% of the volume of the typical Maryland prescriber of this medication (32.8). Medicare paid an average of $9.13 per fill, versus $13.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 23 30-Day Fills standardized to 30-day supplies 284 Days of Medication total across all patients in 2024 | |||
| RestasisCyclosporine | 19 | $1,495.75 | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 19 Medicare prescriptions for Restasis, about half the volume of the typical Maryland prescriber of this medication (37.6). Medicare paid an average of $1,495.75 per fill, versus $1,183.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 47 30-Day Fills standardized to 30-day supplies 1,410 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 17 | $34.23▼ below MD avg | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 17 Medicare prescriptions for Prednisolone Acetate, about 17% of the volume of the typical Maryland prescriber of this medication (97.8). Medicare paid an average of $34.23 per fill, versus $45.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 22.9 30-Day Fills standardized to 30-day supplies 640 Days of Medication total across all patients in 2024 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 11 | $270.87▼ below MD avg | ▼ Less than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2024, this provider wrote 11 Medicare prescriptions for Simbrinza, about a third of the volume of the typical Maryland prescriber of this medication (28.5). Medicare paid an average of $270.87 per fill, versus $294.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 15 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. ANNA PARK MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Silver Spring, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MD prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
